These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2888550

  • 1. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
    Lamberts SW, Verleun T, Hofland L, Del Pozo E.
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):11-23. PubMed ID: 2888550
    [Abstract] [Full Text] [Related]

  • 2. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion.
    Lamberts SW, Verleun T, Zuiderwijk JM, Oosterom R.
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995
    [Abstract] [Full Text] [Related]

  • 3. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW, Zweens M, Klijn JG, van Vroonhoven CC, Stefanko SZ, Del Pozo E.
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
    [Abstract] [Full Text] [Related]

  • 4. A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo.
    Lamberts SW, van Koetsveld P, Hofland L.
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):401-10. PubMed ID: 2627746
    [Abstract] [Full Text] [Related]

  • 5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 6. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW, Zweens M, Verschoor L, del Pozo E.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [Abstract] [Full Text] [Related]

  • 7. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ, Liuzzi A.
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term in-vitro treatment of human growth hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels.
    Hofland LJ, Velkeniers B, vd Lely AJ, van Koetsveld PM, Kazemzadeh M, Waaijers M, Hooghe-Peters EL, Lamberts SW.
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):240-8. PubMed ID: 1424206
    [Abstract] [Full Text] [Related]

  • 13. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
    Prysor-Jones RA, Kennedy SJ, O'Sullivan JP, Jenkins JS.
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372
    [Abstract] [Full Text] [Related]

  • 14. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [Abstract] [Full Text] [Related]

  • 15. [Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture].
    Deng J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):330-4. PubMed ID: 1966332
    [Abstract] [Full Text] [Related]

  • 16. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
    van der Lely AJ, Harris AG, Lamberts SW.
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):181-5. PubMed ID: 1395069
    [Abstract] [Full Text] [Related]

  • 17. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    Lamberts SW, Oosterom R, Neufeld M, del Pozo E.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119
    [Abstract] [Full Text] [Related]

  • 18. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T, Bai X, Liu K, Hu W, Xue D, Jiang X.
    J Tongji Med Univ; 1998 Jun; 18(3):161-3. PubMed ID: 10806816
    [Abstract] [Full Text] [Related]

  • 19. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
    Dubuis JM, Deal CL, Drews RT, Goodyer CG, Lagacé G, Asa SL, Van Vliet G, Collu R.
    Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T, Thellung S, Corsaro A, Bocca L, Arena S, Pattarozzi A, Villa V, Massa A, Diana F, Schettini D, Barbieri F, Ravetti JL, Spaziante R, Giusti M, Schettini G.
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.